Phospholipid hydrolytic enzymes in a 'cesspool' of arterial intimal lipoproteins: A mechanism for atherogenic lipid accumulation

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 21, Issue 6, 2001, Pages 884-886

  Guyton, John R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Atherosclerosis; Fibrous plaque; Low density lipoproteins; Phospholipase A2; Sphingomyelin

Indexed keywords

LOW DENSITY LIPOPROTEIN; PHOSPHOLIPASE A2;

ATHEROSCLEROTIC PLAQUE; EDITORIAL; ENZYME ACTIVITY; FOAM CELL; HUMAN; LIPID HYDROLYSIS; LIPID OXIDATION; LIPID STORAGE; LIPOPROTEIN BLOOD LEVEL; MACROPHAGE FUNCTION; PRIORITY JOURNAL;

EID: 0035718731     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.21.6.884     Document Type: Editorial

References (30)

1. 2 induces particle fusion and enhances the retention of LDL by human aortic proteoglycans
2. Development of the lipid-rich core in human atherosclerosis
3. Human aortic fibrolipid lesions: Progenitor lesions for fibrous plaques, exhibiting early formation of the cholesterol-rich core
4. Development of the atherosclerotic core region: Chemical and ultrastructural analysis of microdissected atherosclerotic lesions from human aorta
5. The relationship between plasma and tissue lipids in human atherosclerosis
6. Quantitative ultrastructural analysis of perifibrous lipid and its association with elastin in nonatherosclerotic human aorta
7. Ultrastructure of the human aortic fibrolipid lesion: Formation of the atherosclerotic lipid-rich core
8. Atheroma formation: Defective control in the intimal round-trip of cholesterol
9. Altered ultrastructural morphology of self-aggregated low density lipoproteins: Coalescence of lipid domains forming droplets and vesicles
10. Lipid accumulation in rabbit aortic intima 2 hours after bolus infusion of low density lipoprotein
11. Oxidation of low density lipoprotein leads to particle aggregation and altered macrophage recognition
12. Phagocytosis of aggregated lipoprotein by macrophages: Low density lipoprotein receptor-dependent foam-cell formation
13. Modification of low density lipoproteins by secretory granules of rat serosal mast cells
14. Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH: Implications for atherosclerotic lesion development
15. Sphingomyelinase, an enzyme implicated in atherogenesis, is present in atherosclerotic lesions and binds to specific components of the subendothelial extracellular matrix
16. Human vascular endothelial cells are a rich and regulatable source of secretory sphingomyelinase: Implications for early atherogenesis and ceramide-mediated cell signaling
17. Acute systemic inflammation up-regulates secretory sphingomyelinase in vivo: A possible link between inflammatory cytokines and atherogenesis
18. 2 in atherosclerosis
19. Interferon-γ induces secretory group IIA phospholipase A2 in human arterial smooth muscle cells: Involvement of cell differentiation, STAT-3 activation, and modulation by other cytokines
20. Secretory group II phospholipase A2 in human atherosclerotic plaques
21. 2 in normal and atherosclerotic arteries: Activity of the isolated enzyme on low-density lipoproteins
22. 2 in atherosclerotic and nonatherosclerotic regions of human arteries
23. 2 induces particle aggregation in the absence and fusion in the presence of heparin
24. The response-to-retention hypothesis of early atherogenesis
25. The response-to-retention hypothesis of atherogenesis reinforced
26. 2 in atherosclerosis, 1: Increased atherogenesis and altered lipoproteins in transgenic mice expressing group IIa phospholipase A2
27. 2 predict coronary events in patients with coronary artery disease
28. Quantification of apolipoprotein B in grossly normal human aorta
29. Low-density lipoprotein concentration in interstitial fluid from human atherosclerotic lesions: Relation to theories of endothelial damage and lipoprotein binding
30. Pathogenesis of atherosclerosis: Lipid metabolism